Vericel VCEL 深 滬
已收盤 09-19 16:00:00 美东时间
48.03
+1.680
+3.62%
華盛通- 最 高50.00
- 今 開47.83
- 成交量 62.77万股
- 最 低 47.355
- 昨 收 46.35
- 總市值 22.88亿
- 52周最高 54.10
- 市盈率 靜 --
- 換手率 1.32%
- 52周最低 30.18
- 委 比 -85.26%
- 總股本 4764.22万
- 歷史最高 68.94
- 量 比 1.67
- 振 幅 5.71%
- 歷史最低 1.69
- 每 手 1
- 風險率 6.20%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多纳斯达克生物科技指数收跌0.13%，猴痘疫情概念股普跌
成分股Phathom Pharma收涨12.77%领跑，Verve Therapeutics涨8.02%，Vericel也涨7.25%；Pacific Bio...
08-28 04:54
The Analyst Verdict: Vericel In The Eyes Of 7 Experts
In the preceding three months, 7 analysts have released ratings for Vericel (NA...
08-28 02:00
Buy Rating on Vericel: Expanding Market Reach with FDA-Approved MACI Arthro Platform
Vericel (VCEL – Research Report), the Healthcare sector company, was revisited ...
08-27 00:45
Vericel announces FDA approval, commercial availability of MACI Arthro
Vericel (NASDAQ:VCEL) has announced that the U.S. FDA has approved a supplemental Biologics License Application expanding the MACI® label to include arthroscopic delivery of MACI to repair symptomatic...
08-26 19:54
快讯 | 维瑞塞尔公司向混合货架发行注册申请后，股价下跌1.4%。
Vericel Corp Shares Down 1.4% After Co Files for Mixed Shelf Offering
08-19 22:22
Vericel files automatic mixed securities shelf
Vericel (NASDAQ:VCEL) filed for automatic mixed securities shelf. Filing More on Vericel Vericel gets FDA approval for NexoBrid for pediatric burn patients Vericel GAAP EPS of -$0.10 misses by $0.01, ...
08-17 04:15
快讯 | Vericel公司向SEC申报混合货架招股; 大小未披露-SEC备案
Vericel Corp Files for Mixed Shelf Offering; Size Not Disclosed- SEC Filing
08-17 04:07
Vericel gets FDA approval for NexoBrid for pediatric burn patients
Vericel (NASDAQ:VCEL) has received FDA approval for its burn care therapy NexoBrid in the treatment of children with severe thermal burns. NexoBrid was approved for the removal of eschar, or dead tiss...
08-16 04:39
快讯 | vericel宣布Nexobrid获得FDA批准，用于治疗儿童严重烧伤患者
Vericel Announces FDA Approval of Nexobrid for the Treatment of Pediatric Patie...
08-16 04:05
